Executive summary
Demand is demographically non-discretionary
Japan crossed 36.3 million people aged 65 and over — 29.3% of the population in 2024 [Govt stats 2024], with more than one in ten now aged 80 or older. The old-age dependency ratio is projected to climb from 39% in 2020 to 71% by 2040 [Govt stats 2024]. This cohort drives the highest-utilisation device categories — diagnostic imaging, cardiovascular intervention, orthopedic implants, and in-vitro diagnostics — independent of the economic cycle, anchoring a market that grows even as the total population shrinks.
Reform redraws the price floor
The FY2026 medical fee revision pairs a +3.09% increase in the fee body — the first positive whole-package revision in over a decade — with a marginal −0.01% materials price change [Chuikyo 2025]. More structurally, Chuikyo approved a first-ever reverse-margin (gyaku-zaya) correction: where hospitals' purchase price has exceeded the reimbursed price under a weak yen, certain device categories now receive an actual-price-based uplift [Chuikyo 2025]. The signal is a shift from pure cost containment toward supply-security and clinical-value pricing.